← Open Payments lookup

ALAM KHAN: Open Payments

NPI 1316946288 · CHICAGO, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$685 in 27 payments from 12 companies in 2025. Trend: 2023 $1,515 · 2024 $1,277 · 2025 $685

Food & beverage: $574Education: $111
CompanyPaymentsAmount
Teva Pharmaceuticals USA, Inc.5$177
PFIZER INC.4$83
Otsuka America Pharmaceutical, Inc.3$72
Amgen Inc.3$69
Novartis Pharmaceuticals Corporation2$61
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)4$61
Lilly USA, LLC1$34
ABBVIE INC.1$29
AstraZeneca Pharmaceuticals LP1$28
Boehringer Ingelheim Pharmaceuticals, Inc.1$26

Products named: REXULTI, ELIQUIS, AUSTEDO XR, LEQVIO, CAPLYTA, KRYSTEXXA, MOUNJARO, VRAYLAR.

Industry payments across IL — which companies pay providers there.